Fecal α1-proteinase inhibitor concentration in dogs with chronic gastrointestinal disease

Veterinary Clinical Pathology

Volumn 32, Issue 2, 2003, Pages 67-72

  Murphy, K F ^a   German, A J ^a,c   Ruaux, C G ^b   Steiner, J M ^b   Williams, D A ^b   Hall, E J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Albumin; Dog; Inflammatory bowel disease; Lymphangiectasia; Protein losing enteropathy; 1 proteinase inhibitor

Indexed keywords

ALPHA 1 ANTITRYPSIN; SERUM ALBUMIN; SERINE PROTEINASE INHIBITOR;

ALBUMIN BLOOD LEVEL; ARTICLE; CHRONICITY; DOG; DUODENUM BIOPSY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; GASTROINTESTINAL DISEASE; HISTOLOGY; LYMPHANGIECTASIS; NONHUMAN; PROTEIN EXPRESSION; SAMPLE; SPECIES COMPARISON; STOMACH BIOPSY; ANIMAL; ANIMAL DISEASE; BIOPSY; CHEMISTRY; CHRONIC DISEASE; DOG DISEASE; FECES; FEMALE; MALE; METABOLISM; PATHOLOGY; PROTEIN LOSING GASTROENTEROPATHY;

CANIS FAMILIARIS;

ALPHA 1-ANTITRYPSIN; ANIMALS; BIOPSY; CHRONIC DISEASE; DOG DISEASES; DOGS; FECES; FEMALE; GASTROINTESTINAL DISEASES; INFLAMMATORY BOWEL DISEASES; MALE; PROTEIN-LOSING ENTEROPATHIES; SERINE PROTEINASE INHIBITORS; SERUM ALBUMIN;

EID: 0042352143     PISSN: 02756382     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2003.tb00316.x     Document Type: Article

References (21)

1. Willard MD. Disorders of the intestinal tract. In: Nelson RW, Couto CG, eds. Small Animal Internal Medicine. 2nd ed. Mosby Inc, St Louis, MO; 1998:453.
2. Hall EJ. Clinical laboratory evaluation of small intestinal function. Vet Clin North Am Small Anim Pract. 1999;29:441-469.
3. Thomas DW, Sinatra FR, Merritt RJ. Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease. Gastroenterology. 1981;80:776-782.
4. Elzouki AN, Eriksson S, Lofberg R, Nassberger L, Wieslander J, Lindgren S. The prevalence and clinical significance of alpha(1)-antitrypsin deficiency and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis. Inflammatory Bowel Dis. 1999;5:246-252.
5. Melgarejo T. Novel Approaches for the Diagnosis of Protein-Losing Enteropathy and Small Intestinal Bacterial Overgrowth in Dogs [PhD thesis]. West Lafayette, IN: Purdue University; 1999.
6. Vaden SL, Sellon RK, Melgarejo LT, et al. Evaluation of intestinal permeability and gluten sensitivity in Soft-Coated Wheaten Terriers with familial protein-losing enteropathy, protein-losing nephropathy or both. Am J Vet Res. 2000;61:518-524.
7. 1 protease inhibitor in dogs with diet-responsive and other bowel disease and response to treatment [abstract]. Proc ESVIM Congress. Dublin, Ireland; 2001:54.
8. 1-PI) concentration as a test for canine protein losing enteropathy (PLE) [abstract]. J Vet Intern Med. 1991;5:133.
9. Mohr AJ, Leisewitz LS, Jacobson JM, Steiner JM, Ruaux CG, Williams DA. Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with parvovirosis [abstract]. Proc 19th ACVIM Forum. Denver, CO; 2001:840.
10. Koenig A, Slater M, Ruaux CG, Steiner JM, Williams DA. Comparison of fecal alpha1-proteinase inhibitor concentration in fecal samples obtained via spontaneous defaecation and rectal palpation [abstract]. Proc 20th ACVIM Forum. Dallas, TX; 2002:763.
11. Roth L, Walton AM, Leib MS, Burrows CF. A grading system for lymphocytic plasmacytic colitis in dogs. J Vet Diagn Invest. 1990;2:257-262.
12. Jergens AE, Moore FM, Haynes JS, Miles KG. Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987-1990). J Am Vet Med Assoc. 1992;201:1603-1608.
13. Jergens AE. Inflammatory bowel disease - current perspectives. Vet Clin North Am Small Anim Pract. 1999;29:501-521.
14. 1-protease inhibitor. Am J Vet Res. 1998;59:127-130.
15. MacDonald TT, Bajaj-Elliott M, Pender SLF. T cells orchestrate intestinal mucosal shape and integrity. Immunol Today. 1999;20:505-510.
16. Playford RJ, Hanby AM, Patel K, Calam J. Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin-inhibitor within the colon. Am J Pathol. 1995;146:310-316.
17. 1-antitrypsin clearance in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1984;3:56-61.
18. Quigley EMM, Ross IN, Haeney MR, Holbrook IB, Marsh MN. Reassessment of faecal α-1-antitrypsin excretion for use as a screening test for intestinal protein loss. J Clin Pathol. 1987;40:61-66.
19. Florent C, L'Hirondel C, Desmazures C, Aymes C, Bernier JJ. Intestinal clearance of alpha 1-antitrypsin A sensitive method for the detection of protein losing enteropathy. Gastroenterology. 1981;81:777-780.
20. Molmenti EP, Perlmutter DH, Rubin DC. Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest. 1993;92:2022-2034.
21. Stuffer MHM, Ewe K, Gierlasinski B, Prun H, Zutt M. Elevated serum alpha 1-antitrypsin does not cause increased fecal alpha 1-at excretion in patients with normal bowel. Zeitschrift für Gastroenterologie. 1991;29:11-15.